Ado-Trastuzumab Emtansine Biosimilar - Research Grade
Bulk Ado-trastuzumab emtansine - Research Grade
Product Benefits:ichorbio's Ado-trastuzumab emtansine Biosimilar - Research Grade is manufactured in a cGMP compliant facility. Our ado-trastuzumab emtansine biosimilar is for research use only (RUO).
Size:ichorbio's research grade ado-trastuzumab emantsine biosimilar is available in the following sizes: 5mg, 20mg, 100mg ichorbio regularly manufactures bulk multi-gram amounts of our ado-trastuzumab emantsine biosimilar - please contact us for pricing.
Target:ErbB2
Clone:n/a
Isotype:IgG1
Other Names:Receptor tyrosine-protein kinase erbB-2, MLN 19, HER2, HER2/neu
Host:Humanized
Species Reactivity:Human
Specificity:Detects human HER2.
Purification Method:This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Background:Ado-trastuzumab emtansine is a HER2-targeted antibody-drug conjugate which contains the humanized anti-HER2 IgG1, trastuzumab, covalently linked to the microtubule inhibitory drug DM1 via the stable thioether linker MCC. Trastuzumab is produced by Chinese hamster ovary cells, and DM1-MCC are produced by chemical synthesis. Ado-trastuzumab emtansine contains an average of 3.5 DM1 molecules per antibody.
Concentration:1.0 - 5.0 mg/ml
Formulation:Sterile, colorless liquid without preservatives, containing polysorbate 20, sodium succinate, sucrose, pH 5.0. BSA and Azide free.
Purity:>95% by SDS-PAGE and HPLC
Endotoxin:≤ 0.75 EU/mg as determined by the LAL method
Storage:This antibody is stable for at least 4 weeks when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at – 20°C or -80°C. Avoid repeated freeze thaw cycles.
Applications:Functional Assays
Application Notes:Each investigator should determine their own optimal working dilution for specific applications.
Use: ichorbio's ado-trastuzumab biosimilar emtansine is for research use only (RUO). Isotype Control:| Concentration | 12.25mg/ml |
|---|---|
| Isotype | IgG1 |
| Host | Humanized |
| Use | Products are for research use only. Not for use in diagnostic or therapeutic procedures. |
| Storage | Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at ï؟½80°C. Avoid Repeated Freeze Thaw Cycles. |
| Endotoxin | ≤ 1.0 EU/mg as determined by the LAL method |
| Purity | >95% by SDS-PAGE and HPLC |
| Formulation | Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free. |
| Purification Method | This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype. |
| Specificity | Detects human HER2. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Ado-trastuzumab emtansine. |
| Species Reactivity | Human |
| Target | HER2 |
| Shipping Conditions | Blue ice |
| background | Ado-trastuzumab emtansine is a HER2-targeted antibody-drug conjugate which contains the humanized anti-HER2 IgG1, trastuzumab, covalently linked to the microtubule inhibitory drug DM1 via the stable thioether linker MCC. Trastuzumab is produced by Chinese |
| Other names | Receptor tyrosine-protein kinase erbB-2, MLN 19, HER2, HER2/neu |
| UniProt | P04626 |
| Buffer | ICH3001-100ml ICH3002-100ml ICH3003-100ml |
| Sequence | https://www.imgt.org/mAb-DB/ |